CN109363044A - A kind of functional beverage and preparation method containing water-soluble capejasmine extract - Google Patents
A kind of functional beverage and preparation method containing water-soluble capejasmine extract Download PDFInfo
- Publication number
- CN109363044A CN109363044A CN201811482204.8A CN201811482204A CN109363044A CN 109363044 A CN109363044 A CN 109363044A CN 201811482204 A CN201811482204 A CN 201811482204A CN 109363044 A CN109363044 A CN 109363044A
- Authority
- CN
- China
- Prior art keywords
- soluble
- water
- parts
- capejasmine
- capejasmine extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000018958 Gardenia augusta Nutrition 0.000 title claims abstract description 56
- 244000111489 Gardenia augusta Species 0.000 title claims abstract description 50
- 239000000284 extract Substances 0.000 title claims abstract description 44
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims description 12
- 235000013361 beverage Nutrition 0.000 claims abstract description 21
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 19
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 19
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 3
- 239000011782 vitamin Substances 0.000 claims abstract description 3
- 235000013343 vitamin Nutrition 0.000 claims abstract description 3
- 229940088594 vitamin Drugs 0.000 claims abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 22
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 14
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 11
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 claims description 11
- 229930003268 Vitamin C Natural products 0.000 claims description 11
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 claims description 11
- 239000011718 vitamin C Substances 0.000 claims description 11
- 235000019154 vitamin C Nutrition 0.000 claims description 11
- 239000011268 mixed slurry Substances 0.000 claims description 9
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims 1
- 230000003179 granulation Effects 0.000 claims 1
- 206010023126 Jaundice Diseases 0.000 abstract description 18
- 238000005516 engineering process Methods 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 5
- 238000011156 evaluation Methods 0.000 abstract description 4
- 230000000968 intestinal effect Effects 0.000 abstract description 4
- 230000001580 bacterial effect Effects 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 3
- 230000029142 excretion Effects 0.000 abstract description 3
- 210000004072 lung Anatomy 0.000 abstract description 3
- 239000003094 microcapsule Substances 0.000 abstract description 3
- 238000005253 cladding Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 210000000232 gallbladder Anatomy 0.000 description 7
- 240000001972 Gardenia jasminoides Species 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000001054 red pigment Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000008865 yin zhi huang Substances 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- HVHKMUMXERBUAN-IFADSCNNSA-N mesobilirubin IXalpha Chemical compound N1C(=O)C(CC)=C(C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C)C(=O)N\3)CC)N2)CCC(O)=O)N1 HVHKMUMXERBUAN-IFADSCNNSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of functional beverage containing water-soluble capejasmine extract, the raw material including following parts by weight: 10-70 parts of water-soluble capejasmine extracts, 5-30 parts of galactooligosaccharides, 5-30 parts of stachyoses, 1-10 portions of maltodextrins and 0.01-0.1 parts of vitamin Cs.Pass through microcapsules technology cladding and the collocation of suitable component formula, obtain a kind of functional solid beverage containing water-soluble capejasmine extract of the invention, not only rush molten fast, delicate mouthfeel, and Evaluation of Intestinal Bacterial Colonies In Newborns can be improved, promote to absorb, accelerates metabolism, calming the liver and benefiting the lungs, it is not influencing normally to feed premise, is reaching auxiliary conducive to excretion is absorbed and accelerate jaundice.
Description
Technical field
The present invention relates to functional food field more particularly to a kind of functional beverage containing water-soluble capejasmine extract and
Preparation method.
Background technique
Jaundice is common sympton and sign, is to cause bilirubin concentration in serum due to bilirubin metabolism obstacle
Caused by raising.Clinical signs are that sclera, mucous membrane, skin and its hetero-organization are dyed to yellow.Especially newborn often goes out
Existing physiologic jaundice, i.e., serum bilirubin is stepped up to 86 μ by connatae 17-51 μm of ol/L after newborn's birth for 24 hours
Clinically there is jaundice without other symptoms, subsides in 1-2 weeks in mol/L or more.The method of processing physiologic jaundice has at present
Blue-light treatment, drug therapy, Blood exchanging therapy etc., drug therapy such as Yinzhihuang oral liquor, main component are capejasmine extract, according to
Document report, cape jasmine (Gardenia jasminoides Ellis), also referred to as Yellow Fructus Gardeniae, mountain Cape jasmine, white toad, are madder wort Cape jasmines
The fruit of son.The fruit of cape jasmine is traditional Chinese medicine, belongs to the l batches of medical and edible dual purpose plant resources that the Ministry of Public Health promulgates, main component
For Gardenoside, have the effects that protect liver, cholagogue, jaundice with damp-heat pathogen, decompression, calmness, hemostasis, detumescence, such as patent
CN200310103393.0 discloses a kind of injection for treating hepatopathy and its production technology, with Herba Artemisiae Scopariae, mast, Radix Isatidis, spirit
The techniques such as sesame and radix scutellariae medicinal materials are extracted, purification, mixing, ultrafiltration, filtering are formulated, and Yinzhihuang oral liquor is dropped with removing jaundice
Enzyme, enhancing immunocompetence, liver protecting and other effects, but cape jasmine herb liquid will affect neonatal digestive tract function, promote baby
There are the side effects such as nausea,vomiting,diarrhea in intestinal microecology dysequilibrium, and Gardenoside stability is poor, and ester group facile hydrolysis is at Cape jasmine
Sub- aglycon, reacted with other polar substances such as amino acid generate pigment intermediate, after high temperature or oxygen effect under aoxidize
Or coupling polymerization, it is on the one hand perishable in process, it is not easy drying, increases technology difficulty, another aspect removing jaundice effect is big
It is big to reduce.Therefore, it is necessary to develop a kind of functional beverage and preparation method thereof containing water-soluble capejasmine extract, solve existing
The problem of with the presence of technology.
Summary of the invention
The present invention provides a kind of functional beverage containing water-soluble capejasmine extract, solves existing containing cape jasmine extraction
The traditional Chinese medicine oral liquid stability of object is poor, the strong problem of side effect.
A kind of functional beverage containing water-soluble capejasmine extract of one aspect of the present invention includes following raw material: water-soluble Cape jasmine
Seed extract, galactooligosaccharide, stachyose, vitamin C, maltodextrin.
Preferably, the composition by weight of raw material are as follows: 10-70 parts of water-soluble capejasmine extracts, 5-30 parts of galactooligosaccharides, 5-30
Part stachyose, 1-10 portions of maltodextrins and 0.01-0.1 parts of vitamin Cs.
Preferably, the composition by weight of raw material are as follows: 50 parts of water-soluble capejasmine extracts, 20 parts of galactooligosaccharides, 20 parts of woods
Sugar, 10 portions of maltodextrins and 0.1 part of vitamin C.
Preferably, 10%-40% Gardenoside is contained in water-soluble capejasmine extract.
On the other hand a kind of preparation method of functional beverage containing water-soluble capejasmine extract, including following step are provided
It is rapid: first to weigh galactooligosaccharide, stachyose and maltodextrin according to composition of raw materials and be added in warm water, add again after constant temperature stirring and dissolving
Enter water-soluble capejasmine extract and vitamin C homogeneous obtains mixed slurry, concentration mixed slurry makes its soluble solid
200；Mixed slurry is dried using Highspeedcentrifugingandsprayingdrier, 120 DEG C of inlet temperature, 70 DEG C of outlet temperature, is fed
Beverage particles are made in speed 80mL/min.
Using a kind of resolving functions beverage containing water-soluble capejasmine extract provided by the present invention, not only mouthfeel is thin
It is greasy, improve Evaluation of Intestinal Bacterial Colonies In Newborns, promote to absorb, accelerate metabolism, calming the liver and benefiting the lungs is not influencing normally to feed premise, is conducive to inhale
It receives excretion and reaches auxiliary and accelerate jaundice.
Further, this processing method without the high temperature infusion of Chinese medicine long-time handle, do not destroy effective component structure and
Prepare that dissolubility is good, drying property is good under the premise of effect, beverage particles of the water content without departing from 2%, simple process and low cost,
It is suitable for mass production.In particular by the galactooligosaccharide, stachyose and maltodextrin centainly matched as wall material, water-soluble Cape jasmine
Seed extract and vitamin C are embedded object, the beverage particles stable structure obtained by microcapsules technology spray drying, without adding
Add agent, long shelf-life does not influence baby's gastrointestinal disturbances ability when drinking.
Specific embodiment
The principles and features of the present invention are described below, and illustrated embodiment is served only for explaining the present invention, is not intended to
It limits the scope of the invention.
The water-soluble capejasmine extract that the present invention selects, effective component are iridoid substance, including Gardenoside, capital Buddhist nun
Flat glycosides, Gardenoside, cape jasmine thuja acid etc., it is Gardenoside that wherein active constituent is highest, though it can obviously reduce in blood and tip
Bilirubin in lymph can promote blood mesobilirubin and drain rapidly, but be easily destroyed intestinal microflora balance.
Galactooligosaccharide (Galactooligosaccharides, GOS) is that a kind of functionality with natural attribute is oligomeric
Sugar, molecular structure are usually that 1-7 galactosyl is connected on galactolipin or glucose molecule.
Stachyose is a kind of naturally occurring tetrose, is a kind of function of can significantly promote the beneficial bacteriums such as Bifidobacterium proliferation
Property oligosaccharide, sugariness is low, can improve environment in human body alimentary canal rapidly, adjusts Tiny ecosystem colony balance.
Maltodextrin, with polysaccharide made of α -1,4 key phase-polymerizations, has good mouthfeel using D-Glucose as structural units
With instant thickening effect.
Vitamin C organic trace compounds essential to growth, to the metabolism of body, growth and development, healthy pole
To be important, redox metabolism reaction can be adjusted rapidly after removing jaundice.
A kind of embodiment one: preparation method of the functional solid beverage containing capejasmine extract, comprising the following steps:
1, it mixes homogeneous: first weighing 0.2kg galactooligosaccharide, 0.2kg stachyose and 0.1kg maltodextrin and 3L warm water is added
In, in 60 DEG C of constant temperature stirring and dissolvings, add 0.5kg water solubility capejasmine extract (Gardenoside containing 30% weight content) and
0.001kg vitamin C is 20MPa in pressure, and temperature is that homogeneous obtains mixed slurry at 80 DEG C, and concentration mixed slurry makes it can
Dissolubility solid content is 20 °；
2, it is spray-dried: mixed slurry being dried using Highspeedcentrifugingandsprayingdrier, 120 DEG C of inlet temperature, out
Beverage particles are made in mouth temperature 70 C, charging rate 80mL/min.
Beverage particles of the invention are prepared in milk yellow using micro capsule technology, particle is uniform, and it is good to rush dissolubility, rehydration deutostoma
Sense is fine and smooth.
Embodiment two: the difference of embodiment two and embodiment one is raw material dosage difference, specially 0.7kg water solubility Cape jasmine
Seed extract (Gardenoside containing 10% weight content), 0.05kg galactooligosaccharide, 0.05kg stachyose, 0.1kg malt paste
Essence and 0.0001kg vitamin C.
Embodiment three: the difference of embodiment three and embodiment one is raw material dosage difference, specially 0.1kg water solubility Cape jasmine
Seed extract (Gardenoside containing 40% weight content), 0.3kg galactooligosaccharide, 0.3kg stachyose, 0.05kg maltodextrin
With 0.005kg vitamin C.
Example IV: the difference of example IV and embodiment one is, does not add galactooligosaccharide and stachyose.
Embodiment five: the preparation method of water-soluble capejasmine extract includes that will first use cape jasmine medicine materical crude slice coarse powder, every 1kg cape jasmine
Coarse powder adds 6L water, and refluxing extraction 2 times, each 1h, 4000r/min are centrifuged 10min, merges centrifuged supernatant, is concentrated into solid-to-liquid ratio
For the medicinal extract of 1:10, the water-soluble capejasmine extract (cape jasmine after tested containing 30% weight content of acquisition is dried under reduced pressure at 60 DEG C
Glycosides), the water-soluble capejasmine extract of different Determination of Gardenoside can be obtained by return time, centrifugation degree.
One, beverage primary sensory's index test prepared by the embodiment of the present invention one to four is evaluated first, as a result such as table
One:
The beverage main indicator test evaluation of 1 the embodiment of the present invention one to four of table preparation
As seen from the results in Table 1, solid beverage mouthfeel can not only be promoted by adding galactooligosaccharide and stachyose, can be used as cyst wall
Water-soluble capejasmine extract is coated, grain forming is easy to, is spray-dried, micron particles are full uniformly, and aridity reaches food
It is required that extend the shelf life under the premise of additive-free, and galactooligosaccharide and stachyose can promote species population proliferation,
Improve stomach microenvironment, reduces side effect of the water-soluble capejasmine extract to stomach.
Two, zoopery
Animal: Kunming mouse is provided by Hainan Medical College's animal house, male, 18~24g of weight, by 50 test mices
After number, random number grouping is divided into 5 groups, is set to 1 group, 2 groups, 3 groups, blank control group and model group；Wherein 1 group, 2 groups,
3 groups of beverage 10mg/kg for giving the embodiment of the present invention one to embodiment three respectively are shared medicine 3 days, in the 3rd day 2 times a day
Give CCl in the afternoon4Contamination, 1 group, 2 groups, 3 groups and model group mouse give 0.1%CCl by 10mg/kg4Peanut oil solution, blank
Control group such as feeds at the capacity peanut oil, after fasting 16h, mouse broken end is taken blood, serum is separated, surveys ALT and TBIL.
The beverage of the present invention of table 2 is to the glutamic-pyruvic transaminase (ALT) and total bilirubin in carbon tetrachloride poisoning mouse serum
(TBIL) influence
| Group | ALT(u/dL) | TBIL(umol/L) |
| 1 | 256 | 10.25 |
| 2 | 245 | 10.10 |
| 3 | 260 | 10.22 |
| Blank group | 32 | 9.53 |
| Model group | 852 | 12.53 |
The experimental results showed that, solid beverage of the invention is fed to mouse from table 2, have for the hepatic injury of mouse certain
Protective effect, while total bilirubin can be reduced, to play jaundice.
Three, finally on probation in effect is carried out after the bath of 5mg/1mL ratio to the solid beverage of the embodiment of the present invention one, it selects
Its skin gallbladder red pigment value is surveyed between 130um/L and 227um/L after taking out raw 48h and is the baby of mature normal birth.
Lee, male, gives birth to 3 days back mesh skin distinctness yellow, and it is 152.5um/L that skin gallbladder red pigment value, which is up to, on inspection,
Stool once two days, takes the drinks of embodiment one, and each 5mg, 3 times a day, after 3 days, appearance flavedo disappears,
After 5 days, jaundice is moved back entirely, and stool and urine is normal, and skin gallbladder haematochrome is normal on inspection.
Mr. Wang, female give birth to 5 days back mesh skin distinctness yellow, and it is 180.6um/L that skin gallbladder red pigment value, which is up to, on inspection,
The jaundice of infant appearance, urine jaundice, stool once two days, take the drinks of embodiment two, each 5mg, 3 times a day, 5 days
Afterwards, appearance flavedo disappears, and after 8 days, jaundice is moved back entirely, and stool and urine is normal, and skin gallbladder haematochrome is normal on inspection.
Lee, male, gives birth to 3 days back mesh skin distinctness yellow, and it is 161.2um/L that skin gallbladder red pigment value, which is up to, on inspection,
The jaundice of infant appearance, urine jaundice, stool once three days, take the drinks of embodiment three, each 5mg, 3 times a day, 4 days
Afterwards, appearance flavedo disappears, and after 6 days, jaundice is moved back entirely, and stool and urine is normal, and skin gallbladder haematochrome is normal on inspection.
In conclusion using a kind of preparation side of the functional liquid beverage containing capejasmine extract provided by the present invention
Method, by selecting proper ratio water solubility capejasmine extract, galactooligosaccharide and stachyose to be processed as solid beverage, mouthfeel
Exquisiteness, it is good to rush dissolubility, and preparation process is simple, be suitble to industrialized production, can improve Evaluation of Intestinal Bacterial Colonies In Newborns through Efficacy experiments verifying,
Promote to absorb, accelerate metabolism, calming the liver and benefiting the lungs is not influencing normally to feed premise, reaches auxiliary conducive to excretion is absorbed and accelerates to move back
Huang effect.
Further, this processing method boils processing it is not necessary that long-time high temperature is whole, is not destroying effective component structure and effect
Under prepare that dissolubility is good, drying property is good, beverage particles of the water content without departing from 2%, long shelf-life.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Within mind and principle, any modification, equivalent substitution, improvement and etc. done be should be included within the scope of the present invention.
Claims (6)
1. a kind of functional beverage containing water-soluble capejasmine extract, it is characterised in that: the beverage is prepared by following raw material
And obtain: water-soluble capejasmine extract, galactooligosaccharide, stachyose, maltodextrin and vitamin C.
2. a kind of functional beverage containing water-soluble capejasmine extract according to claim 1, it is characterised in that: described
Beverage is prepared by the raw material of following parts by weight: 10-70 parts of water-soluble capejasmine extracts, 5-30 parts of galactooligosaccharides, 5-
30 parts of stachyoses, 1-10 portions of maltodextrins and 0.01-0.1 parts of vitamin Cs.
3. a kind of functional beverage containing water-soluble capejasmine extract according to claim 2, it is characterised in that: described
Beverage is prepared by the raw material of following parts by weight: 50 parts of water-soluble capejasmine extracts, 20 parts of galactooligosaccharides, 20 parts of woods
Sugar, 10 portions of maltodextrins and 0.1 part of vitamin C.
4. a kind of functional beverage containing water-soluble capejasmine extract according to claim 1-3, feature
It is: contains 10%-40% Gardenoside in the water solubility capejasmine extract.
5. a kind of described in any item preparation methods of the functional beverage containing water-soluble capejasmine extract of claim 1-4,
Characterized by the following steps: galactooligosaccharide, stachyose and maltodextrin are first weighed according to composition of raw materials, and warm water is added
In, water-soluble capejasmine extract and vitamin C are added after 60 DEG C of constant temperature stirring and dissolvings, is 20MPa in pressure, temperature is 80 DEG C
Lower homogeneous obtains mixed slurry, and concentration mixed slurry makes its soluble solid 200；Use Highspeedcentrifugingandsprayingdrier pair
Mixed slurry is dried granulation, and 120 DEG C of inlet temperature, 70 DEG C of outlet temperature, charging rate 80mL/min.
6. a kind of preparation method of functional beverage containing water-soluble capejasmine extract according to claim 5, special
Sign is that the water solubility capejasmine extract is prepared by the following: first will be using cape jasmine medicine materical crude slice coarse powder, every 1kg cape jasmine is thick
Powder adds 6L water, and refluxing extraction 2 times, each 1h, 4000r/min are centrifuged 10min, merges centrifuged supernatant, recycle-water to medicinal extract,
60 DEG C are dried under reduced pressure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811482204.8A CN109363044A (en) | 2018-12-05 | 2018-12-05 | A kind of functional beverage and preparation method containing water-soluble capejasmine extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811482204.8A CN109363044A (en) | 2018-12-05 | 2018-12-05 | A kind of functional beverage and preparation method containing water-soluble capejasmine extract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109363044A true CN109363044A (en) | 2019-02-22 |
Family
ID=65375751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811482204.8A Pending CN109363044A (en) | 2018-12-05 | 2018-12-05 | A kind of functional beverage and preparation method containing water-soluble capejasmine extract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109363044A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021020210A1 (en) * | 2019-07-26 | 2021-02-04 | 小林製薬株式会社 | Gut microbiota regulating agent |
| CN114681477A (en) * | 2020-12-29 | 2022-07-01 | 中国科学院上海药物研究所 | Application of iridoid glycoside compound in regulating intestinal flora |
| CN114681477B (en) * | 2020-12-29 | 2024-06-11 | 中国科学院上海药物研究所 | Application of iridoid glycoside compound in regulating intestinal flora |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09229A (en) * | 1995-06-19 | 1997-01-07 | Kiguchi:Kk | Tea mainly derived from ginko leaf and araliaceae and cape jasmine and beverage based on the tea, their production, the tea plus roasted unpolished rice and green tea, beverage based on this tea, and their production |
| CN1466951A (en) * | 2002-07-12 | 2004-01-14 | 范崔生 | Gardenoside general extracts preparation and making method and uses |
| CN1517326A (en) * | 2002-07-12 | 2004-08-04 | 范崔生 | Capejasmine cycloolefines ether terpene extract and its preparation method and use |
| CN1706442A (en) * | 2005-05-30 | 2005-12-14 | 许建文 | Prepn process of medicine for treating icteric diseases and oral liquid containing the medicine |
| CN102114102A (en) * | 2011-02-28 | 2011-07-06 | 山东省中医药研究院 | Traditional Chinese medicine extract mixed preparation and application thereof |
| CN102389073A (en) * | 2011-11-17 | 2012-03-28 | 中国食品发酵工业研究院 | Natural plant extract formula for liver protection |
| CN103735633A (en) * | 2013-12-30 | 2014-04-23 | 南京博士牛生物科技有限公司 | Preparation method of instant gardenia powder |
| CN105918740A (en) * | 2016-04-21 | 2016-09-07 | 厦门华普高新技术产业有限公司 | Functional drink containing gardenia jasminoides ellis extract and preparation method of functional drink |
-
2018
- 2018-12-05 CN CN201811482204.8A patent/CN109363044A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09229A (en) * | 1995-06-19 | 1997-01-07 | Kiguchi:Kk | Tea mainly derived from ginko leaf and araliaceae and cape jasmine and beverage based on the tea, their production, the tea plus roasted unpolished rice and green tea, beverage based on this tea, and their production |
| CN1466951A (en) * | 2002-07-12 | 2004-01-14 | 范崔生 | Gardenoside general extracts preparation and making method and uses |
| CN1517326A (en) * | 2002-07-12 | 2004-08-04 | 范崔生 | Capejasmine cycloolefines ether terpene extract and its preparation method and use |
| CN1706442A (en) * | 2005-05-30 | 2005-12-14 | 许建文 | Prepn process of medicine for treating icteric diseases and oral liquid containing the medicine |
| CN102114102A (en) * | 2011-02-28 | 2011-07-06 | 山东省中医药研究院 | Traditional Chinese medicine extract mixed preparation and application thereof |
| CN102389073A (en) * | 2011-11-17 | 2012-03-28 | 中国食品发酵工业研究院 | Natural plant extract formula for liver protection |
| CN103735633A (en) * | 2013-12-30 | 2014-04-23 | 南京博士牛生物科技有限公司 | Preparation method of instant gardenia powder |
| CN105918740A (en) * | 2016-04-21 | 2016-09-07 | 厦门华普高新技术产业有限公司 | Functional drink containing gardenia jasminoides ellis extract and preparation method of functional drink |
Non-Patent Citations (2)
| Title |
|---|
| 姜锡瑞等: "《生物发酵产业技术》", 31 May 2016, 中国轻工业出版社 * |
| 孙志伟等: ""京尼平苷微囊的制备及体外评价孙志伟"", 《黑龙江医药》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021020210A1 (en) * | 2019-07-26 | 2021-02-04 | 小林製薬株式会社 | Gut microbiota regulating agent |
| JP2021019527A (en) * | 2019-07-26 | 2021-02-18 | 小林製薬株式会社 | Intestinal bacterial flora regulating agent |
| JP7409798B2 (en) | 2019-07-26 | 2024-01-09 | 小林製薬株式会社 | Intestinal flora regulator |
| CN114681477A (en) * | 2020-12-29 | 2022-07-01 | 中国科学院上海药物研究所 | Application of iridoid glycoside compound in regulating intestinal flora |
| CN114681477B (en) * | 2020-12-29 | 2024-06-11 | 中国科学院上海药物研究所 | Application of iridoid glycoside compound in regulating intestinal flora |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100998611A (en) | Huishuhua fermentation preparation process using Chinese herb medicine as medium | |
| CN106420847A (en) | Composition for auxiliary protection of gastric mucosa and/or remission of gastrectasia and microecological preparation thereof | |
| CN101474375A (en) | Compound Cordyceps militaris L. Link preparation and production method and application | |
| CN102961596B (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of for traditional Chinese medicine composition | |
| WO2010037256A1 (en) | Composition for reducing blood fat and blood glucose | |
| CN109528814A (en) | A kind of probiotics and its preparation method and application of lactobacillus-fermented Radix Astragali | |
| CN103155985B (en) | Rhizoma polygonati nutrition powder and preparation method thereof | |
| CN102139053A (en) | Shrimp fertile-benefiting growth promoter | |
| CN109363044A (en) | A kind of functional beverage and preparation method containing water-soluble capejasmine extract | |
| CN101664180A (en) | Health-care nutritional complexing agent with effect of and preparation method thereof | |
| CN1977885B (en) | Antihepatitis medicinal composition | |
| CN110448590B (en) | Oriental millettia root extract with sexual function enhancing effect, and preparation method and application thereof | |
| CN102764294A (en) | Cough relieving and sputum eliminating combination and preparation method thereof | |
| CN106039138A (en) | Lactic acid bacteria traditional Chinese medicine fermentation antiviral preparation for aquaculture | |
| CN106728077B (en) | Composition with functions of regulating intestinal flora structure and preventing and treating constipation and preparation method and application thereof | |
| CN110301633A (en) | A kind of healthy food and preparation method thereof improving male's sex-health | |
| CN101904500B (en) | Functional food for enhancing immunity and preparation method thereof | |
| CN110420258A (en) | A kind of cherokee rose root extract and its preparation method and application with establishing-Yang | |
| WO2010037255A1 (en) | The usage of ginseng and gynostemma pentaphyllum compound preparation in manufacture of medicaments with the effects of lipid regulation and blood-sugar regulation | |
| CN101991722B (en) | Shiqi exogenous disease-treating traditional Chinese medicinal capsules | |
| CN105495599A (en) | Blood-fat reducing soft capsule and preparing method thereof | |
| CN103251715B (en) | Composition for regulating Th1/Th2 cell ratio and preparation method thereof | |
| CN102727863B (en) | Combined drug of compound fermented Cordyceps sinensis powder and ginsenoside Rg1 | |
| CN1449753A (en) | Chlorogenic acid and isochlorogenic acid composition and medical use thereof | |
| CN102688334A (en) | Chinese and western medicine mixture for improving immunologic function of livestock and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |